vimarsana.com
Home
Live Updates
Subcutaneous Immunoglobulin Maintains HRQoL Among Patients W
Subcutaneous Immunoglobulin Maintains HRQoL Among Patients W
Subcutaneous Immunoglobulin Maintains HRQoL Among Patients With CIDP
In patients with CIDP, health-related quality of life with IVIg was also maintained with facilitated subcutaneous immunoglobulin treatment.
Related Keywords
Phoenix ,
Arizona ,
United States ,
,
American Association Of Neuromuscular Electrodiagnostic Medicine ,
Electrodiagnostic Medicine ,
Annual Meeting ,
Rasch Built Overall Disability Scale ,
Item Short Form ,
Treatment Satisfaction Questionnaire ,